Boston, MA -- (SBWIRE) -- 08/19/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Ruckus Wireless Inc (NYSE:RKUS), Brandywine Realty Trust (NYSE:BDN), TASER International, Inc. (NASDAQ:TASR), Osiris Therapeutics, Inc. (NASDAQ:OSIR)
Ruckus Wireless Inc (NYSE:RKUS) shares jumped 2.73% to $14.32. The company on July 31 announced financial results for its second quarter of 2013 ended June 30, 2013. Revenue for the second quarter of 2013 was $63.9 million, an increase of 30.6% from the second quarter of 2012. GAAP net income for the second quarter of 2013 was $0.7 million, compared with GAAP net income of $20.6 million in the second quarter of 2012. Non-GAAP net income for the second quarter of 2013 was $4.7 million, compared with non-GAAP net income of $23.2 million in the second quarter of 2012.
Is RKUS A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Brandywine Realty Trust (NYSE:BDN) shares dropped 3.53% and closed at $12.56. The company on July 24 reported its financial and operating results for the three and six-month period ended June 30, 2013. Net income allocated to common shares totaled $5.3 million or $0.03 per diluted share in the second quarter of 2013 compared to net income of $1.5 million or $0.01 per diluted share in the second quarter of 2012. Core Funds from Operations available to common shares and units (FFO) in the second quarter of 2013 totaled $50.2 million or $0.32 per diluted share versus $48.0 million or $0.33 per diluted share in the second quarter of 2012.
Is BDN A Good Buy After The Recent Price Movement? Find Out Here
TASER International, Inc. (NASDAQ:TASR) shares jumped 4.18% and closed at $10.21 in the last trading session. The company on August 14 announced the Surprise Police Department will issue AXON flex™ on-officer cameras and EVIDENCE.com service for all patrol officers following a year-long research and training period. Frazier says department research also discovered that other communities reported declines in police encounter complaints after body cameras were put into use.
How Should Investors Trade TASR After The Recent Volatility? Get Free Report Here
Osiris Therapeutics, Inc. (NASDAQ:OSIR) stock dropped 1.41% to $19.48. The company on August 13 said its Grafix stem-cell treatment for chronic diabetic foot ulcers met primary and secondary endpoints in a recent clinical trial that compared the product with conventional treatment. The study included 131 diabetes patients who received weekly applications of Grafix or conventional treatment. In the trial, 62% of patients receiving Grafix had complete wound closure compared with only 21% of patients who received conventional treatment.
How Should Investors Trade OSIR After The Recent Volatility? Get Free Report Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)